Experimental evidence has suggested that drugs that enhance cannabinoid type-1 (CB1) receptor activity may induce anxiolytic and antidepressant effects, whilst the opposite has been reported with antagonists. Thus, the objective of the present review is to discuss the potential psychiatric side-effects of CB1 receptor antagonists, such as rimonabant, which has been recently marketed in several countries for the treatment of smoking cessation, obesity and associated metabolic disorders.
Pharmacology, Toxicology and Pharmaceutical Science
28
10%
Biochemistry, Genetics and Molecular Biology
24
8%
Other
50
18%
Unknown
76
27%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 92. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2026.
All research outputs
#583,194
of 34,342,227 outputs
Outputs from Brazilian Journal of Psychiatry
#14
of 1,038 outputs
Outputs of similar age
#1,397
of 175,697 outputs
Outputs of similar age from Brazilian Journal of Psychiatry
#1
of 10 outputs
Altmetric has tracked 34,342,227 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,038 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,697 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them
